The upper pulmonary veins (PVs) are responsible for the majority of atrial fibrillation (AF) triggering foci, whereas the inferior PVs are more difficult to ablate and prone to postablation ostial ...

Boston Scientific (NYSE: BSX) today announced positive 12-month study results for its Farapulse pulsed field ablation (PFA) ...

These foci are commonly in the superior pulmonary veins; this is an important factor in the electrophysiologic approach to atrial fibrillation, known as pulmonary vein isolation. Less commonly ...

A majority of cases of atrial fibrillation originate within the pulmonary veins. Ablation of atrial fibrillation, also known as “pulmonary vein isolation” or PVI, electrically disconnects the ...

Under a canopy of eight heart-monitoring screens in a cardiac catheterization lab on a recent Monday, Mayo Clinic doctors briefly paused a procedure treating atrial fibrillation to inspect a new tool: ...

Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced the initiation of the ...

Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of ...

The study subjects were 51 consecutive patients with highly symptomatic permanent (n = 25) or persistent (n = 26) atrial fibrillation resistant to, or intolerant of, drug therapy. Atrial ...

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

Two state-of-the-art new technologies for transcatheter tricuspid valve replacements is expanding advanced heart care with ...

The pulse frequency is faster and reduces the risk of injury to the surrounding tissue, including the esophagus, which is close to where Wright's AFib was in the pulmonary veins. The radio ...